Dysadherin expression in gastrointestinal stromal tumors (GISTs). 2009

Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
Department of Pathology, The First Affiliated Hospital, Shanxi Medical University, 030001 Taiyuan, China. Jfliang2000@yahoo.com.cn

The purpose of this study was to detect the protein and mRNA expression of dysadherin and to investigate the clinical significance of dysadherin expression in gastrointestinal stromal tumors (GISTs). Twenty fresh GISTs samples were used for testing the mRNA of dysadherin and E-cadherin by reverse-transcription polymerase chain reaction (RT-PCR). In addition, 54 paraffin blocks of GISTs cases were also used for the investigation of dysadherin and E-cadherin using immunohistochemistry. The dysadherin expression level was significantly correlated with GISTs risk stratification (chi(2)=5.769, P<0.05), but was not related to age, sex, histologic subtype, and location (P>0.05). There was only faint or absent E-cadherin protein expression in GISTs. The expression level of dysadherin is related to the risk of GISTs. Dysadherin upregulation, which may cause loss of E-cadherin, is one of the reasons for GISTs recurrence and metastasis. It seems that dysadherin protein detection is a promising method for GISTs prognostication.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008840 Microfilament Proteins Monomeric subunits of primarily globular ACTIN and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell. Actin Binding Protein,Actin-Binding Protein,Actin-Binding Proteins,Microfilament Protein,Actin Binding Proteins,Binding Protein, Actin,Protein, Actin Binding,Protein, Actin-Binding,Protein, Microfilament,Proteins, Actin-Binding,Proteins, Microfilament
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
January 2005, Polskie Archiwum Medycyny Wewnetrznej,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
March 2004, Current opinion in gastroenterology,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
February 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
January 2007, Revista espanola de enfermedades digestivas,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
July 2003, Molecular immunology,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
June 2010, Revista espanola de enfermedades digestivas,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
January 2017, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
February 2012, Japanese journal of radiology,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
December 2010, Digestive diseases and sciences,
Jian Fang Liang, and Hui Xia Zheng, and Hong Xiao, and Ning Li, and Cai Xia Cheng, and Hong Kun Wang
January 2006, Hepato-gastroenterology,
Copied contents to your clipboard!